• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2019冠状病毒病大流行的流行病学:全球范围内的康复率和死亡率

Epidemiology of CoViD-19 Pandemic: Recovery and mortality ratio around the globe.

作者信息

Noor Aziz Ullah, Maqbool Farhana, Bhatti Zulfiqar A, Khan Asmat Ullah

机构信息

Aziz Ullah Noor, Department of Microbiology, Faculty of Health Sciences, Hazara University, Mansehra, Khyber Pakhtunkhwa, Pakistan.

Farhana Maqbool, Ph.D. Department of Microbiology, Faculty of Health Sciences, Hazara University, Mansehra, Khyber Pakhtunkhwa, Pakistan.

出版信息

Pak J Med Sci. 2020 May;36(COVID19-S4):S79-S84. doi: 10.12669/pjms.36.COVID19-S4.2660.

DOI:10.12669/pjms.36.COVID19-S4.2660
PMID:32582319
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7306958/
Abstract

Coronavirus Disease 2019 (CoViD-19) is the third type of coronavirus disease after severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS) that appears in human population from the past two decades. It is highly contagious and rapidly spread in the human population and compelled global public health institutions on high alert. Due to genetic similarity of this novel coronavirus 2019 with bat virus its emergence from bat to humans is possible. The virus survive in the droplets of coughing and sneezing and spread around the large areas through infected person resulting in its rapid spread among people. Clinical symptoms of CoViD-19 include fever, dry cough, dyspnea, loose stool, nausea and vomiting. The present review discuss the origin of CoViD-19, its rapid spread, mortality rate and recoveries ratio around the world. Since its origin from Wuhan, the CoViD-19 spread very rapidly all across the countries, on April 17, 2020 this disease has affected 210 countries of the globe. The data obtained showed over 2.4 million confirmed cases of CoViD-19. Higher mortality rate was found in Algeria and Belgium as 15% and 13.95%, respectively. Lower mortality rate was found in Qatar 0.17% and Singapore 0.2%. Recovery versus deceased ratio showed that recovery was 68, 59 and 35 times higher than the death in Singapore, Qatar and Thailand respectively. It is concluded that 2019-novel corona virus is a zoonotic pathogen similar to MERS and SARS. Therefore, a barrier should be maintained between and across the human, household and wild animals to avoid such pandemics.

摘要

2019冠状病毒病(COVID-19)是过去二十年来在人类群体中出现的继严重急性呼吸综合征(SARS)和中东呼吸综合征(MERS)之后的第三种冠状病毒病。它具有高度传染性,在人群中迅速传播,迫使全球公共卫生机构处于高度戒备状态。由于这种新型2019冠状病毒与蝙蝠病毒在基因上相似,它有可能从蝙蝠传播到人类。该病毒在咳嗽和打喷嚏的飞沫中存活,并通过感染者在大面积区域传播,导致其在人群中迅速传播。COVID-19的临床症状包括发热、干咳、呼吸困难、腹泻、恶心和呕吐。本综述讨论了COVID-19的起源、其迅速传播、全球死亡率和康复率。自起源于武汉以来,COVID-19在各国迅速传播,2020年4月17日,这种疾病已影响到全球210个国家。获得的数据显示,COVID-19确诊病例超过240万例。阿尔及利亚和比利时的死亡率较高,分别为15%和13.95%。卡塔尔的死亡率较低,为0.17%,新加坡为0.2%。康复与死亡比率显示,新加坡、卡塔尔和泰国的康复率分别比死亡率高68倍、59倍和35倍。结论是,2019新型冠状病毒是一种与MERS和SARS类似的人畜共患病原体。因此,应在人类、家畜和野生动物之间及相互之间保持隔离,以避免此类大流行。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c65/7306958/ec46c274a7d7/PJMS-36-S79-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c65/7306958/ec46c274a7d7/PJMS-36-S79-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c65/7306958/ec46c274a7d7/PJMS-36-S79-g001.jpg

相似文献

1
Epidemiology of CoViD-19 Pandemic: Recovery and mortality ratio around the globe.2019冠状病毒病大流行的流行病学:全球范围内的康复率和死亡率
Pak J Med Sci. 2020 May;36(COVID19-S4):S79-S84. doi: 10.12669/pjms.36.COVID19-S4.2660.
2
Novel coronavirus 2019-nCoV: prevalence, biological and clinical characteristics comparison with SARS-CoV and MERS-CoV.新型冠状病毒 2019-nCoV:流行情况、与 SARS-CoV 和 MERS-CoV 的生物学和临床特征比较。
Eur Rev Med Pharmacol Sci. 2020 Feb;24(4):2012-2019. doi: 10.26355/eurrev_202002_20379.
3
The novel zoonotic COVID-19 pandemic: An expected global health concern.新型人畜共患的新冠疫情:一个意料之中的全球卫生问题。
J Infect Dev Ctries. 2020 Mar 31;14(3):254-264. doi: 10.3855/jidc.12671.
4
COVID-19: A Global Challenge with Old History, Epidemiology and Progress So Far.COVID-19:具有悠久历史、流行病学和迄今进展的全球性挑战。
Molecules. 2020 Dec 23;26(1):39. doi: 10.3390/molecules26010039.
5
Modeling and tracking Covid-19 cases using Big Data analytics on HPCC system platformm.在惠普高性能计算集群(HPCC)系统平台上使用大数据分析对新冠病毒疾病(Covid-19)病例进行建模和追踪。
J Big Data. 2021;8(1):33. doi: 10.1186/s40537-021-00423-z. Epub 2021 Feb 15.
6
COVID-19: A Worldwide, Zoonotic, Pandemic Outbreak.新型冠状病毒肺炎:一场全球性的人畜共患病大流行疫情。
Altern Ther Health Med. 2020 Aug;26(S2):56-64.
7
Rapid and sensitive diagnostic procedure for multiple detection of pandemic Coronaviridae family members SARS-CoV-2, SARS-CoV, MERS-CoV and HCoV: a translational research and cooperation between the Phan Chau Trinh University in Vietnam and University of Bari "Aldo Moro" in Italy.用于 SARS-CoV-2、SARS-CoV、MERS-CoV 和 HCoV 大流行冠状病毒科家族成员的快速和敏感的多重检测的诊断程序:越南范周仁大学与意大利巴里大学“阿尔多·莫罗”之间的转化研究与合作。
Eur Rev Med Pharmacol Sci. 2020 Jun;24(12):7173-7191. doi: 10.26355/eurrev_202006_21713.
8
Human and novel coronavirus infections in children: a review.儿童人感染和新型冠状病毒感染:综述。
Paediatr Int Child Health. 2021 Feb;41(1):36-55. doi: 10.1080/20469047.2020.1781356. Epub 2020 Jun 25.
9
Prediction of the COVID-19 Pandemic for the Top 15 Affected Countries: Advanced Autoregressive Integrated Moving Average (ARIMA) Model.预测受 COVID-19 影响最严重的 15 个国家:高级自回归综合移动平均 (ARIMA) 模型。
JMIR Public Health Surveill. 2020 May 13;6(2):e19115. doi: 10.2196/19115.
10
SARS-CoV-2 infection: a global outbreak and its implication on public health.严重急性呼吸综合征冠状病毒2感染:全球大流行及其对公共卫生的影响
Bull Natl Res Cent. 2021;45(1):139. doi: 10.1186/s42269-021-00599-7. Epub 2021 Aug 3.

引用本文的文献

1
Fine-grained forecasting of COVID-19 trends at the county level in the United States.美国县级层面新冠疫情趋势的细粒度预测。
NPJ Digit Med. 2025 Apr 11;8(1):204. doi: 10.1038/s41746-025-01606-1.
2
Covid-19, Diagnostic History and Mortality from Medicare 1999-2021, In an All-Cause Mortality Approach.采用全因死亡率方法分析1999 - 2021年医疗保险数据中的新冠病毒疾病、诊断史及死亡率
Arch Intern Med Res. 2023;6(4):74-85. doi: 10.26502/aimr.0151. Epub 2023 Oct 30.
3
LDH and NLR, as inflammatory markers, the independent risk factors for COVID-19 complicated with respiratory failure in elderly patients.

本文引用的文献

1
Imaging Profile of the COVID-19 Infection: Radiologic Findings and Literature Review.新型冠状病毒肺炎感染的影像学表现:放射学发现与文献综述
Radiol Cardiothorac Imaging. 2020 Feb 13;2(1):e200034. doi: 10.1148/ryct.2020200034. eCollection 2020 Feb.
2
Structural basis of SARS-CoV-2 3CL and anti-COVID-19 drug discovery from medicinal plants.严重急性呼吸综合征冠状病毒2 3CL的结构基础与药用植物抗新型冠状病毒药物发现
J Pharm Anal. 2020 Aug;10(4):313-319. doi: 10.1016/j.jpha.2020.03.009. Epub 2020 Mar 26.
3
Regulators split on antimalarials for COVID-19.
乳酸脱氢酶(LDH)和中性粒细胞与淋巴细胞比值(NLR)作为炎症标志物,是老年患者新冠病毒疾病(COVID-19)并发呼吸衰竭的独立危险因素。
Pak J Med Sci. 2024 Oct;40(9):2112-2117. doi: 10.12669/pjms.40.9.8728.
4
The effect of quercetin supplementation on clinical outcomes in COVID-19 patients: A systematic review and meta-analysis.补充槲皮素对COVID-19患者临床结局的影响:一项系统评价和荟萃分析。
Food Sci Nutr. 2023 Sep 26;11(12):7504-7514. doi: 10.1002/fsn3.3715. eCollection 2023 Dec.
5
Filter-Free, Harmless, and Single-Wavelength Far UV-C Germicidal Light for Reducing Airborne Pathogenic Viral Infection.无滤光片、无害、单波长远紫外线 C 杀菌灯,可降低空气传播的致病性病毒感染。
Viruses. 2023 Jun 28;15(7):1463. doi: 10.3390/v15071463.
6
Knowledge, attitudes, and practices of dentists after the COVID-19 pandemic: A cross-sectional study.新冠疫情后牙医的知识、态度和行为:一项横断面研究。
Dent Res J (Isfahan). 2023 Jun 27;20:66. eCollection 2023.
7
A Proposed Pastoral Response to the Increase in the Number of Suicide Cases in the Philippines During the COVID-19 Pandemic.《针对菲律宾新冠肺炎大流行期间自杀案例增多而提出的牧灵应对方案》。
J Relig Health. 2023 Dec;62(6):3887-3903. doi: 10.1007/s10943-023-01865-w. Epub 2023 Jul 5.
8
Predictors of Mortality in COVID-19 patients: An observational study.新冠病毒肺炎患者死亡的预测因素:一项观察性研究。
Pak J Med Sci. 2023 Jan-Feb;39(1):241-247. doi: 10.12669/pjms.39.1.6059.
9
Longitudinal behavioral changes and factors related to reinforced risk aversion behavior among patients with chronic kidney disease during the COVID-19 pandemic.COVID-19 大流行期间慢性肾脏病患者强化风险规避行为的纵向行为变化及相关因素。
Sci Rep. 2022 Sep 22;12(1):15780. doi: 10.1038/s41598-022-19787-0.
10
Study on the correlations of different clinical types with imaging findings at initial diagnosis and clinical laboratory indexes in COVID-19 patients.新型冠状病毒肺炎患者初诊时不同临床类型与影像表现及临床实验室指标的相关性研究
Pak J Med Sci. 2022 Jul-Aug;38(6):1649-1655. doi: 10.12669/pjms.38.6.5091.
监管机构在用于治疗新冠肺炎的抗疟疾药物问题上存在分歧。
Lancet. 2020 Apr 11;395(10231):1179. doi: 10.1016/S0140-6736(20)30817-5.
4
How will country-based mitigation measures influence the course of the COVID-19 epidemic?基于国家的缓解措施将如何影响新冠疫情的发展进程?
Lancet. 2020 Mar 21;395(10228):931-934. doi: 10.1016/S0140-6736(20)30567-5. Epub 2020 Mar 9.
5
Clinical analysis of 10 neonates born to mothers with 2019-nCoV pneumonia.10例新型冠状病毒肺炎母亲所生新生儿的临床分析
Transl Pediatr. 2020 Feb;9(1):51-60. doi: 10.21037/tp.2020.02.06.
6
Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records.九名孕妇感染 COVID-19 的临床特征和宫内垂直传播潜力:病历回顾性研究。
Lancet. 2020 Mar 7;395(10226):809-815. doi: 10.1016/S0140-6736(20)30360-3. Epub 2020 Feb 12.
7
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.《武汉 2019 年新型冠状病毒感染的肺炎 138 例住院患者临床特征分析》
JAMA. 2020 Mar 17;323(11):1061-1069. doi: 10.1001/jama.2020.1585.
8
Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding.新冠病毒的基因组特征和流行病学:对病毒起源和受体结合的影响。
Lancet. 2020 Feb 22;395(10224):565-574. doi: 10.1016/S0140-6736(20)30251-8. Epub 2020 Jan 30.
9
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study.中国武汉 99 例 2019 年新型冠状病毒肺炎患者的流行病学和临床特征:描述性研究。
Lancet. 2020 Feb 15;395(10223):507-513. doi: 10.1016/S0140-6736(20)30211-7. Epub 2020 Jan 30.
10
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.中国武汉地区 2019 年新型冠状病毒感染患者的临床特征。
Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24.